Hiya Banerjee, Ph.D. - Publications

Affiliations: 
2010 Applied Statistics University of California, Riverside, Riverside, CA, United States 
Area:
Statistics, Pharmaceutical Chemistry

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Maloney DG, Ogura M, Fukuhara N, Davis J, Lasher J, Izquierdo M, Banerjee H, Tobinai K. A phase 3 randomized study (HOMER) of ofatumumab vs rituximab in iNHL relapsed after rituximab-containing therapy. Blood Advances. 4: 3886-3893. PMID 32810220 DOI: 10.1182/Bloodadvances.2020001942  0.322
2019 van Oers M, Smolej L, Petrini M, Offner F, Grosicki S, Levin MD, Davis J, Banerjee H, Stefanelli T, Hoever P, Geisler C. Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG study. Blood Cancer Journal. 9: 98. PMID 31801940 DOI: 10.1038/S41408-019-0260-2  0.31
2018 Grosicki S, Lech-Maranda E, Govind Babu K, Rybka J, Litvinskaya E, Loscertales J, Kryachok I, Kłoczko J, Rekhtman G, Homenda W, Blonski J, Stefanelli T, Vincent G, Banerjee H, Robak T. Long-Term Evaluation of Efficacy and Safety of Ofatumumab Added to Fludarabine & Cyclophosphamide in Subjects with Relapsed Chronic Lymphocytic Leukemia: Final Analysis of Complement 2 Trial Blood. 132: 3151-3151. DOI: 10.1182/Blood-2018-99-112139  0.311
2017 Sternberg CN, Donskov F, Haas NB, Doehn C, Russo P, Elmeliegy M, Banerjee H, Aimone P, Voi M, Motzer RJ. Pazopanib exposure-response assessment as adjuvant therapy for patients with localized or locally advanced renal cell carcinoma (RCC) following nephrectomy. Journal of Clinical Oncology. 35: 4564-4564. DOI: 10.1200/Jco.2017.35.15_Suppl.4564  0.318
2016 Basu A, Cajigas-Du Ross CK, Rios-Colon L, Mediavilla-Varela M, Daniels-Wells TR, Leoh LS, Rojas H, Banerjee H, Martinez SR, Acevedo-Martinez S, Casiano CA. LEDGF/p75 Overexpression Attenuates Oxidative Stress-Induced Necrosis and Upregulates the Oxidoreductase ERP57/PDIA3/GRP58 in Prostate Cancer. Plos One. 11: e0146549. PMID 26771192 DOI: 10.1371/Journal.Pone.0146549  0.314
2012 Basu A, Rojas H, Banerjee H, Cabrera IB, Perez KY, De León M, Casiano CA. Expression of the stress response oncoprotein LEDGF/p75 in human cancer: a study of 21 tumor types. Plos One. 7: e30132. PMID 22276150 DOI: 10.1371/Journal.Pone.0030132  0.307
2010 Basu A, Rojas H, Banerjee H, Cabrera IB, Perez KY, Leon MD, Casiano CA. Abstract 4667: Elevated expression of the stress oncoprotein LEDGF/p75 in major human cancers Cancer Research. 70: 4667-4667. DOI: 10.1158/1538-7445.Am10-4667  0.3
2010 Ghosh S, Banerjee H. Methods of finding the initial values of parameters in the maximum likelihood estimating equations for a logistic regression model and comparison of their final solutions using different criterion functions Journal of the Korean Statistical Society. 39: 471-477. DOI: 10.1016/J.Jkss.2009.10.003  0.385
Show low-probability matches.